• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分光光度法和高效液相色谱法评估单剂量和短期口服硝苯地平对吲哚菁绿清除率的影响。

Effects of single-dose and short-term oral nifedipine on indocyanine green clearance as assessed by spectrophotometry and high performance liquid chromatography.

作者信息

Soons P A, Kroon J M, Breimer D D

机构信息

Division of Pharmacology, Leiden University, The Netherlands.

出版信息

J Clin Pharmacol. 1990 Aug;30(8):693-8. doi: 10.1002/j.1552-4604.1990.tb03628.x.

DOI:10.1002/j.1552-4604.1990.tb03628.x
PMID:2401748
Abstract

The effects of single-dose (10 mg) and short-term (10 mg tid) nifedipine treatment on apparent hepatic blood flow, as assessed by indocyanine green (ICG) clearance, were studied in ten healthy male subjects. ICG was measured by both spectrophotometric and high performance liquid chromatography (HPLC) assay methods. Blood clearance of ICG and apparent hepatic blood flow were increased by 30 and 50%, respectively, after single-dose nifedipine, whereas after 4 days' treatment these values were 12 and 30%. The spectrophotometric assay significantly overestimated ICG plasma concentrations from 7 minutes onwards. Although the spectrophotometric and HPLC assay showed marked differences in calculated half-lives and volume of distribution of ICG, the ICG clearance values were similar for the two assay methods.

摘要

在10名健康男性受试者中研究了单剂量(10毫克)和短期(10毫克,每日三次)硝苯地平治疗对通过吲哚菁绿(ICG)清除率评估的表观肝血流量的影响。通过分光光度法和高效液相色谱(HPLC)测定方法测量ICG。单剂量硝苯地平后,ICG的血液清除率和表观肝血流量分别增加了30%和50%,而治疗4天后,这些值分别为12%和30%。从7分钟起,分光光度法显著高估了ICG血浆浓度。尽管分光光度法和HPLC测定法在计算的ICG半衰期和分布容积方面显示出明显差异,但两种测定方法的ICG清除率值相似。

相似文献

1
Effects of single-dose and short-term oral nifedipine on indocyanine green clearance as assessed by spectrophotometry and high performance liquid chromatography.通过分光光度法和高效液相色谱法评估单剂量和短期口服硝苯地平对吲哚菁绿清除率的影响。
J Clin Pharmacol. 1990 Aug;30(8):693-8. doi: 10.1002/j.1552-4604.1990.tb03628.x.
2
Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.硝苯地平治疗对吲哚菁绿和口服普萘洛尔药代动力学的影响。
Eur J Clin Pharmacol. 1989;37(3):257-60. doi: 10.1007/BF00679780.
3
The influence of nifedipine and captopril on liver blood flow in healthy subjects.硝苯地平和卡托普利对健康受试者肝血流量的影响。
Br J Clin Pharmacol. 1998 May;45(5):447-51. doi: 10.1046/j.1365-2125.1998.00709.x.
4
Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.静脉推注和持续输注后完整猪体内吲哚菁绿的血浆清除:分光光度法和高压液相色谱法用于浓度分析的比较
Hepatology. 1993 Dec;18(6):1504-15.
5
Hepatic drug clearance: the effect of age using indocyanine green as a model compound.肝脏药物清除率:以吲哚菁绿为模型化合物研究年龄的影响。
Br J Clin Pharmacol. 1990 Oct;30(4):634-7. doi: 10.1111/j.1365-2125.1990.tb03826.x.
6
Specific assay for the quantitation of indocyanine green in rat plasma using high-performance liquid chromatography with fluorescence detection.使用带荧光检测的高效液相色谱法定量测定大鼠血浆中吲哚菁绿的特异性检测方法。
J Pharm Sci. 1989 Apr;78(4):328-33. doi: 10.1002/jps.2600780414.
7
Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.通过持续输注吲哚菁绿评估健康受试者的肝血流量。
Br J Clin Pharmacol. 1991 Dec;32(6):697-704.
8
Experimental impact of assay-dependent differences in plasma indocyanine green concentration determinations.血浆吲哚菁绿浓度测定中分析方法依赖性差异的实验影响
J Pharmacokinet Biopharm. 1987 Dec;15(6):601-13. doi: 10.1007/BF01068415.
9
Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.硝苯地平、维拉帕米和地尔硫䓬治疗期间安替比林和吲哚菁绿动力学的变化。
Clin Pharmacol Ther. 1986 Aug;40(2):239-42. doi: 10.1038/clpt.1986.169.
10
[The effect of the method of detecting indocyanine green (HPLC, spectrophotometry) on the determination of pharmacokinetic parameters].
Cesk Farm. 1990 Jun;39(4):155-7.

引用本文的文献

1
Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis.肝硬化患者内皮素受体拮抗剂替佐生的血液动力学和药代动力学。
Eur J Clin Pharmacol. 2012 May;68(5):533-41. doi: 10.1007/s00228-011-1157-6. Epub 2011 Nov 20.
2
Effects of abdominal hot compresses on indocyanine green elimination--a randomized cross over study in healthy subjects.腹部热敷对吲哚菁绿清除率的影响——一项在健康受试者中进行的随机交叉研究。
BMC Gastroenterol. 2007 Jul 10;7:27. doi: 10.1186/1471-230X-7-27.
3
Endothelial binding of recombinant tissue plasminogen activator: quantification in vivo using a recirculatory model.
重组组织型纤溶酶原激活剂的内皮细胞结合:使用再循环模型进行体内定量分析。
J Pharmacokinet Pharmacodyn. 2003 Feb;30(1):3-22. doi: 10.1023/a:1023293325245.
4
The influence of nifedipine and captopril on liver blood flow in healthy subjects.硝苯地平和卡托普利对健康受试者肝血流量的影响。
Br J Clin Pharmacol. 1998 May;45(5):447-51. doi: 10.1046/j.1365-2125.1998.00709.x.
5
Increase in plasma propranolol caused by nicardipine is dependent on the delivery rate of propranolol.硝苯地平引起的血浆普萘洛尔增加取决于普萘洛尔的给药速率。
Eur J Clin Pharmacol. 1995;49(1-2):121-5. doi: 10.1007/BF00192370.
6
Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.通过持续输注吲哚菁绿评估健康受试者的肝血流量。
Br J Clin Pharmacol. 1991 Dec;32(6):697-704.